Circulating fibronectin to C-reactive protein ratio and mortality

A biomarker in COPD?

S. F P Man, L. Xing, J. E. Connett, N. R. Anthonisen, Robert A Wise, D. P. Tashkin, X. Zhang, R. Vessey, T. G. Walker, B. R. Celli, D. D. Sin

Research output: Contribution to journalArticle

Abstract

The balance between inflammatory and repair processes is important in maintaining lung homeostasis in chronic obstructive pulmonary disease (COPD). The aim of the present study was to determine whether or not an integrated index of a biomarker involved in inflammation, C-reactive protein (CRP), and another involved in wound repair, fibronectin, may be a good measure to predict clinical outcomes in COPD. Circulating blood levels of CRP and fibronectin were measured in 4,787 individuals with mild-to-moderate COPD who were prospectively followed for >7 yrs after blood collection as part of the Lung Health Study. To assess the balance between repair and inflammation, a simple ratio was calculated by dividing fibronectin levels by CRP levels and a Cox proportional hazards model was used to determine the relationship between this ratio and all-cause and disease-specific causes of mortality. The relationship between the fibronectin to CRP ratio and all-cause mortality was L-shaped. There was an exponential decay in the adjusted hazard function (i.e. the risk of mortality) as the ratio decreased until a value of 148 was reached, beyond which point the hazard function did not change significantly. Similar results were observed for the risk of coronary and cardiovascular mortality. Circulating fibronectin to CRP ratio is significantly associated with all-cause mortality of COPD patients. However, in contrast to other biomarkers, the relationship appears to be L-shaped (and not linear), suggesting a threshold at ∼150. While promising, future studies are needed to validate this simple index as a biomarker in COPD. Copyright

Original languageEnglish (US)
Pages (from-to)1451-1457
Number of pages7
JournalEuropean Respiratory Journal
Volume32
Issue number6
DOIs
StatePublished - Dec 2008

Fingerprint

Fibronectins
C-Reactive Protein
Chronic Obstructive Pulmonary Disease
Biomarkers
Mortality
Inflammation
Lung
Proportional Hazards Models
Homeostasis
Health
Wounds and Injuries

Keywords

  • C-reactive protein
  • Chronic obstructive pulmonary disease
  • Fibronectin
  • Inflammation
  • Mortality
  • Repair

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Man, S. F. P., Xing, L., Connett, J. E., Anthonisen, N. R., Wise, R. A., Tashkin, D. P., ... Sin, D. D. (2008). Circulating fibronectin to C-reactive protein ratio and mortality: A biomarker in COPD? European Respiratory Journal, 32(6), 1451-1457. https://doi.org/10.1183/09031936.00153207

Circulating fibronectin to C-reactive protein ratio and mortality : A biomarker in COPD? / Man, S. F P; Xing, L.; Connett, J. E.; Anthonisen, N. R.; Wise, Robert A; Tashkin, D. P.; Zhang, X.; Vessey, R.; Walker, T. G.; Celli, B. R.; Sin, D. D.

In: European Respiratory Journal, Vol. 32, No. 6, 12.2008, p. 1451-1457.

Research output: Contribution to journalArticle

Man, SFP, Xing, L, Connett, JE, Anthonisen, NR, Wise, RA, Tashkin, DP, Zhang, X, Vessey, R, Walker, TG, Celli, BR & Sin, DD 2008, 'Circulating fibronectin to C-reactive protein ratio and mortality: A biomarker in COPD?', European Respiratory Journal, vol. 32, no. 6, pp. 1451-1457. https://doi.org/10.1183/09031936.00153207
Man, S. F P ; Xing, L. ; Connett, J. E. ; Anthonisen, N. R. ; Wise, Robert A ; Tashkin, D. P. ; Zhang, X. ; Vessey, R. ; Walker, T. G. ; Celli, B. R. ; Sin, D. D. / Circulating fibronectin to C-reactive protein ratio and mortality : A biomarker in COPD?. In: European Respiratory Journal. 2008 ; Vol. 32, No. 6. pp. 1451-1457.
@article{cefb6a30d4b64cc5bb8c14063305a352,
title = "Circulating fibronectin to C-reactive protein ratio and mortality: A biomarker in COPD?",
abstract = "The balance between inflammatory and repair processes is important in maintaining lung homeostasis in chronic obstructive pulmonary disease (COPD). The aim of the present study was to determine whether or not an integrated index of a biomarker involved in inflammation, C-reactive protein (CRP), and another involved in wound repair, fibronectin, may be a good measure to predict clinical outcomes in COPD. Circulating blood levels of CRP and fibronectin were measured in 4,787 individuals with mild-to-moderate COPD who were prospectively followed for >7 yrs after blood collection as part of the Lung Health Study. To assess the balance between repair and inflammation, a simple ratio was calculated by dividing fibronectin levels by CRP levels and a Cox proportional hazards model was used to determine the relationship between this ratio and all-cause and disease-specific causes of mortality. The relationship between the fibronectin to CRP ratio and all-cause mortality was L-shaped. There was an exponential decay in the adjusted hazard function (i.e. the risk of mortality) as the ratio decreased until a value of 148 was reached, beyond which point the hazard function did not change significantly. Similar results were observed for the risk of coronary and cardiovascular mortality. Circulating fibronectin to CRP ratio is significantly associated with all-cause mortality of COPD patients. However, in contrast to other biomarkers, the relationship appears to be L-shaped (and not linear), suggesting a threshold at ∼150. While promising, future studies are needed to validate this simple index as a biomarker in COPD. Copyright",
keywords = "C-reactive protein, Chronic obstructive pulmonary disease, Fibronectin, Inflammation, Mortality, Repair",
author = "Man, {S. F P} and L. Xing and Connett, {J. E.} and Anthonisen, {N. R.} and Wise, {Robert A} and Tashkin, {D. P.} and X. Zhang and R. Vessey and Walker, {T. G.} and Celli, {B. R.} and Sin, {D. D.}",
year = "2008",
month = "12",
doi = "10.1183/09031936.00153207",
language = "English (US)",
volume = "32",
pages = "1451--1457",
journal = "European Respiratory Journal, Supplement",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "6",

}

TY - JOUR

T1 - Circulating fibronectin to C-reactive protein ratio and mortality

T2 - A biomarker in COPD?

AU - Man, S. F P

AU - Xing, L.

AU - Connett, J. E.

AU - Anthonisen, N. R.

AU - Wise, Robert A

AU - Tashkin, D. P.

AU - Zhang, X.

AU - Vessey, R.

AU - Walker, T. G.

AU - Celli, B. R.

AU - Sin, D. D.

PY - 2008/12

Y1 - 2008/12

N2 - The balance between inflammatory and repair processes is important in maintaining lung homeostasis in chronic obstructive pulmonary disease (COPD). The aim of the present study was to determine whether or not an integrated index of a biomarker involved in inflammation, C-reactive protein (CRP), and another involved in wound repair, fibronectin, may be a good measure to predict clinical outcomes in COPD. Circulating blood levels of CRP and fibronectin were measured in 4,787 individuals with mild-to-moderate COPD who were prospectively followed for >7 yrs after blood collection as part of the Lung Health Study. To assess the balance between repair and inflammation, a simple ratio was calculated by dividing fibronectin levels by CRP levels and a Cox proportional hazards model was used to determine the relationship between this ratio and all-cause and disease-specific causes of mortality. The relationship between the fibronectin to CRP ratio and all-cause mortality was L-shaped. There was an exponential decay in the adjusted hazard function (i.e. the risk of mortality) as the ratio decreased until a value of 148 was reached, beyond which point the hazard function did not change significantly. Similar results were observed for the risk of coronary and cardiovascular mortality. Circulating fibronectin to CRP ratio is significantly associated with all-cause mortality of COPD patients. However, in contrast to other biomarkers, the relationship appears to be L-shaped (and not linear), suggesting a threshold at ∼150. While promising, future studies are needed to validate this simple index as a biomarker in COPD. Copyright

AB - The balance between inflammatory and repair processes is important in maintaining lung homeostasis in chronic obstructive pulmonary disease (COPD). The aim of the present study was to determine whether or not an integrated index of a biomarker involved in inflammation, C-reactive protein (CRP), and another involved in wound repair, fibronectin, may be a good measure to predict clinical outcomes in COPD. Circulating blood levels of CRP and fibronectin were measured in 4,787 individuals with mild-to-moderate COPD who were prospectively followed for >7 yrs after blood collection as part of the Lung Health Study. To assess the balance between repair and inflammation, a simple ratio was calculated by dividing fibronectin levels by CRP levels and a Cox proportional hazards model was used to determine the relationship between this ratio and all-cause and disease-specific causes of mortality. The relationship between the fibronectin to CRP ratio and all-cause mortality was L-shaped. There was an exponential decay in the adjusted hazard function (i.e. the risk of mortality) as the ratio decreased until a value of 148 was reached, beyond which point the hazard function did not change significantly. Similar results were observed for the risk of coronary and cardiovascular mortality. Circulating fibronectin to CRP ratio is significantly associated with all-cause mortality of COPD patients. However, in contrast to other biomarkers, the relationship appears to be L-shaped (and not linear), suggesting a threshold at ∼150. While promising, future studies are needed to validate this simple index as a biomarker in COPD. Copyright

KW - C-reactive protein

KW - Chronic obstructive pulmonary disease

KW - Fibronectin

KW - Inflammation

KW - Mortality

KW - Repair

UR - http://www.scopus.com/inward/record.url?scp=58849157697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58849157697&partnerID=8YFLogxK

U2 - 10.1183/09031936.00153207

DO - 10.1183/09031936.00153207

M3 - Article

VL - 32

SP - 1451

EP - 1457

JO - European Respiratory Journal, Supplement

JF - European Respiratory Journal, Supplement

SN - 0903-1936

IS - 6

ER -